GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ATF5 | hg19_v2_chr19_+_50432400_50432479 | 0.22 | 1.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_52967600 Show fit | 12.74 |
ENST00000549343.1
ENST00000305620.2 |
keratin 74 |
|
chr12_+_104680659 Show fit | 11.05 |
ENST00000526691.1
ENST00000531691.1 ENST00000388854.3 ENST00000354940.6 ENST00000526390.1 ENST00000531689.1 |
thioredoxin reductase 1 |
|
chr12_-_54652060 Show fit | 10.20 |
ENST00000552562.1
|
chromobox homolog 5 |
|
chr7_+_128399002 Show fit | 9.07 |
ENST00000493278.1
|
calumenin |
|
chr17_-_73149921 Show fit | 8.97 |
ENST00000481647.1
ENST00000470924.1 |
hematological and neurological expressed 1 |
|
chr5_+_34757309 Show fit | 8.87 |
ENST00000397449.1
|
retinoic acid induced 14 |
|
chr22_-_36236265 Show fit | 8.16 |
ENST00000414461.2
ENST00000416721.2 ENST00000449924.2 ENST00000262829.7 ENST00000397305.3 |
RNA binding protein, fox-1 homolog (C. elegans) 2 |
|
chr9_+_2622085 Show fit | 7.10 |
ENST00000382099.2
|
very low density lipoprotein receptor |
|
chr14_-_36988882 Show fit | 7.02 |
ENST00000498187.2
|
NK2 homeobox 1 |
|
chr7_-_41740181 Show fit | 6.82 |
ENST00000442711.1
|
inhibin, beta A |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 20.1 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
1.4 | 14.1 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
2.8 | 13.8 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 13.5 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
1.2 | 11.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.2 | 11.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.3 | 10.7 | GO:0036120 | cellular response to platelet-derived growth factor stimulus(GO:0036120) |
0.0 | 10.5 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.0 | 10.3 | GO:0007596 | blood coagulation(GO:0007596) |
3.0 | 9.0 | GO:0006097 | glyoxylate cycle(GO:0006097) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 18.9 | GO:0001650 | fibrillar center(GO:0001650) |
0.4 | 14.1 | GO:0016592 | mediator complex(GO:0016592) |
0.4 | 13.8 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 13.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.3 | 12.3 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 11.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 11.0 | GO:0005884 | actin filament(GO:0005884) |
0.7 | 10.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.1 | 9.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.8 | 9.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 25.3 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.3 | 14.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
3.4 | 13.8 | GO:0038025 | glycoprotein transporter activity(GO:0034437) reelin receptor activity(GO:0038025) |
0.4 | 13.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
2.1 | 12.7 | GO:1990254 | keratin filament binding(GO:1990254) |
3.7 | 11.1 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.2 | 10.7 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 10.2 | GO:0035064 | methylated histone binding(GO:0035064) |
3.0 | 9.0 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.0 | 8.9 | GO:0005509 | calcium ion binding(GO:0005509) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 15.5 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.3 | 13.8 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.4 | 13.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.2 | 11.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 7.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.1 | 7.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.2 | 6.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 6.7 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 6.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 5.9 | NABA COLLAGENS | Genes encoding collagen proteins |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 14.1 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.5 | 13.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 12.2 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 11.2 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 11.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 10.7 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 9.0 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.3 | 7.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 7.2 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 7.1 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |